(Date:11/24/2009).../PRNewswire/--HealthRoboticstodayannounced,thatith...ed,investors.ThisrecentlyformedToronto-basedcompan...andwillmarket,install,andsupport,HealthRobotics,i....onaryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),...eassistanceonan"asneeded,basis"toitsstrategicpartn...
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...ltra-fast communication, computation and more powe...ying to use quantum states as carriers of informat...sicists have shown, mathematically, how to gently ... while keeping the information intact. Their work ...ew Letters and highlighted with a Viewpoint in P...
(Date:11/23/2009)...PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: ...ythatidentifiesandadvancesadiverseportfolioofpromi...ment,todayreportedthatCytopia(ASX:CYT)hascommenced...t,orally-administeredJAK1/JAK2inhibitor.Thetrialis...roposaltomergeCytopiaintoYMhasbeenpreviouslyannoun...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4...Albert Einstein College of Medicine researchers pu...journal -, CLINTON, N.J., Sept. 25 Producing a s...tering an experimental drug from,Ikaria (an inject...lfide),showed promise in a study designed to reduc...ed in the online edition of the Proceedings of the...
...receives $500,000 ,genius award, with ,no strings ...cell biologist at,Fred Hutchinson Cancer Research ...rthur Fellowships, a "genius" award given annually...ion. Roth will receive $500,000 over,five years of... the Hutchinson Center,s Basic Sciences Division, ...
...pt. 25 Earlier today,Signalife announced that it ...3 million (three million three hundred thousand do... of new management,s initial sales campaign. In,th...hat is $5.28 million of,sales orders of our Fideli...e Company, and -- as we fulfill our existing order...
Other Biology Technology:New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces 2New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces 3Basic Scientist Mark Roth Wins MacArthur Fellowship 2Basic Scientist Mark Roth Wins MacArthur Fellowship 3Signalife Receives Another $3.3 Million Sales Orders 2Phosphate Colorimetric Assay Kit from BioAssay Systems
EnzChek cellulase substrate *blue fluorescent, 339/452 from Invitrogen
... Ladder is suitable for sizing single-stranded RNA...dehyde agarose gels. The ladder consists of nine b...0 kb) to simplify size estimation. The 1.5 kb band...y orientation and identification of RNA bands on t...
CpGenome™ Universal DNA Modification Kit from Upstate
Biology Products: